Report ID: SQMIG35A2624
Report ID:
SQMIG35A2624 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
94 |
Figures:
76
North America dominated the market in terms of revenue share in 2022 due to the region's strong healthcare infrastructure, quick development of novel treatments and technologies for throat cancer, and expanding presence of major companies. The market is expected to rise primarily a result of important factors like increased healthcare spending per person and a high prevalence of respiratory ailments. The expansion of the North American regional market is also projected to be boosted by supportive government efforts and an increase in research collaborations.
Asia Pacific is anticipated to expand the quickest among all regions, with a CAGR of 5.2% over the forecast period. The Asia Pacific area has rapidly expanded as a result of the highly crowded and polluted nations in the region, which lead to a rise in respiratory illnesses. Over the course of the projection period, it is predicted that the rapid development of in-home medical and therapeutic services will also raise product demand in Asia Pacific.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2624